Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd.
Summary
Revenue :
000,000 M USD
Finance :
000,000 M USD
Earning Cap :
000,000 M USD
Invest :
000,000 M USD
R & D :
0000 People
Growth :
00% AGR
DIGDAL CAP
Overview
| General Introduction | Jiangsu Nuotai Aosanuo Biopharmaceutical Co., Ltd. is a biopharmaceutical enterprise that focuses on peptide drugs and small molecule drugs, combining independent research and customized research and development. The company is a national high-tech enterprise and a provincial-level technology oriented enterprise, established in April 2009, located in the National Lianyungang Economic and Technological Development Zone. The company was listed on the Science and Technology Innovation Board of the Shanghai Stock Exchange on May 20, 2021 (stock abbreviation: Nuotai Biotech, code: 688076), with over 900 employees. |
| Headquarter | Lianyungang City |
| Establish Date | 4/3/2009 |
| Listed Code | 688076.SH |
| Listed Date | 5/20/2021 |
| Chairman | Tong Zi Quan. |
| CEO | Tong Zi Quan. |
| Website | www.sinopep.cn |
Buy Premium Now
$15/month billed now
View the full stack of insights immediately
Or 7 Days Free Charge for Trial
See feature available in the Trial and Premium
See our Solution and Servicetrial.solutionservice.trial
See our Uniquness and Value deliveringtrial.solutionservice.trial
